Sight Sciences, Inc.

SGHT Medical devices

Develops devices for glaucoma and dry eye treatments.

Jun 2026Revenue $83.4M/yrExpenses $111M/yr
No trendCash runway ≈ 3.4 years from Jun 2026
Figures by year

When will Sight Sciences be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $83.4M and expenses $111M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$77.4M$114M−$37.1M
Dec 2024$79.9M$130M−$50.5M
Dec 2023$81.1M$138M−$57.3M
Dec 2022$71.3M$155M−$84.0M
Dec 2021$49.0M$100M−$51.5M
Dec 2020$27.6M$59.8M−$32.2M